Author
Listed:
- Paul Elliott
(School of Public Health, Imperial College London
MRC Centre for Environment and Health, School of Public Health, Imperial College London
Imperial College Healthcare NHS Trust
National Institute for Health Research Imperial Biomedical Research Centre)
- Oliver Eales
(School of Public Health, Imperial College London
MRC Centre for Global infectious Disease Analysis
Imperial College London)
- Barbara Bodinier
(School of Public Health, Imperial College London
MRC Centre for Environment and Health, School of Public Health, Imperial College London)
- David Tang
(School of Public Health, Imperial College London
MRC Centre for Environment and Health, School of Public Health, Imperial College London)
- Haowei Wang
(School of Public Health, Imperial College London
MRC Centre for Global infectious Disease Analysis
Imperial College London)
- Jakob Jonnerby
(School of Public Health, Imperial College London
National Heart and Lung Institute, Imperial College Healthcare NHS Trust)
- David Haw
(School of Public Health, Imperial College London
MRC Centre for Global infectious Disease Analysis
Imperial College London)
- Joshua Elliott
(Imperial College Healthcare NHS Trust
Imperial College London)
- Matthew Whitaker
(School of Public Health, Imperial College London
MRC Centre for Environment and Health, School of Public Health, Imperial College London)
- Caroline E. Walters
(School of Public Health, Imperial College London
MRC Centre for Global infectious Disease Analysis
Imperial College London)
- Christina Atchison
(School of Public Health, Imperial College London
Imperial College Healthcare NHS Trust)
- Peter J. Diggle
(Lancaster University, UK and Health Data Research)
- Andrew J. Page
(Quadram Institute)
- Alexander J. Trotter
(Quadram Institute)
- Deborah Ashby
(School of Public Health, Imperial College London)
- Wendy Barclay
(Imperial College London)
- Graham Taylor
(Imperial College London)
- Helen Ward
(School of Public Health, Imperial College London
Imperial College Healthcare NHS Trust
National Institute for Health Research Imperial Biomedical Research Centre
MRC Centre for Global infectious Disease Analysis)
- Ara Darzi
(Imperial College Healthcare NHS Trust
National Institute for Health Research Imperial Biomedical Research Centre
Institute of Global Health Innovation, Imperial College London)
- Graham S. Cooke
(Imperial College Healthcare NHS Trust
National Institute for Health Research Imperial Biomedical Research Centre
Imperial College London)
- Marc Chadeau-Hyam
(School of Public Health, Imperial College London
MRC Centre for Environment and Health, School of Public Health, Imperial College London)
- Christl A. Donnelly
(School of Public Health, Imperial College London
MRC Centre for Global infectious Disease Analysis
Imperial College London
University of Oxford)
Abstract
Rapid transmission of the SARS-CoV-2 Omicron variant has led to record-breaking case incidence rates around the world. Since May 2020, the REal-time Assessment of Community Transmission-1 (REACT-1) study tracked the spread of SARS-CoV-2 infection in England through RT-PCR of self-administered throat and nose swabs from randomly-selected participants aged 5 years and over. In January 2022, we found an overall weighted prevalence of 4.41% (n = 102,174), three-fold higher than in November to December 2021; we sequenced 2,374 (99.2%) Omicron infections (19 BA.2), and only 19 (0.79%) Delta, with a growth rate advantage for BA.2 compared to BA.1 or BA.1.1. Prevalence was decreasing overall (reproduction number R = 0.95, 95% credible interval [CrI], 0.93, 0.97), but increasing in children aged 5 to 17 years (R = 1.13, 95% CrI, 1.09, 1.18). In England during January 2022, we observed unprecedented levels of SARS-CoV-2 infection, especially among children, driven by almost complete replacement of Delta by Omicron.
Suggested Citation
Paul Elliott & Oliver Eales & Barbara Bodinier & David Tang & Haowei Wang & Jakob Jonnerby & David Haw & Joshua Elliott & Matthew Whitaker & Caroline E. Walters & Christina Atchison & Peter J. Diggle , 2022.
"Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England,"
Nature Communications, Nature, vol. 13(1), pages 1-10, December.
Handle:
RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-32121-6
DOI: 10.1038/s41467-022-32121-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-32121-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.